Impact of a pan-sarbecovirus dendritic-cell targeting vaccine on SARS-CoV-2 variants
A new study used in silico approaches for designing a next-generation CD40-targeting vaccine, CD40.
Lunla Shutterstock Image Credit Middle East Proteina Affinity T Andb Cell Coronavirus Disease Covid 19
Source: news-medical.net